Back

Epidemiology and outcome of primary and secondary community-acquired bacteraemia in adult patients

Abstract number: 1733_450

Ortega M., Almela M., Martínez J., Marco F., Soriano A., López J., Sánchez M., Muñoz A., Mensa J.

Objectives: To know the associated factors and outcome of community-acquired primary bacteraemia (PB); to describe the most frequently isolated microorganisms, its antibiotic resistance pattern and to guide the most adequate antibiotic treatment.

Patients and Methods: 1640 community-acquired bacteraemias in non-neutropenic adults were consecutively enrolled from January 2003 to May 2006 and prospectively followed up. Non-conditional logistic regression methods were used with PB and death as dependent variables.

Results: 1440 were secondary bacteraemia (SB) and 200 (12%) were PB. The independent factors associated with PB were: male gender (OR: 1.69, 95%CI: 1.27–2.25, p = 0.001), ultimately or rapidly fatal prognosis of underlying disease (OR: 2.48, 95%CI: 1.84–3.34, p = 0.001) and incorrect empirical antibiotic therapy (OR: 2.33, 95%CI: 1.61–3.33, p = 0.001). The most frequently isolated microorganisms in PB were E. coli and other enterobacterias (26% and 22%) and S. aureus (15%). There were 28% and 37% of ciprofloxacin resistant E. coli strains in SB and PB, respectively (p = 0.2). Mortality was significantly higher in PB cases (13% vs 8%, p = 0.04). The independent factors associated with mortality in PB were: ultimately or rapidly fatal prognosis of underlying disease (OR: 2.1, 95%CI: 1.41–3.13, p = 0.001) lack of fever at the moment of bacteraemia (OR: 2.38, 95%CI: 1.18–4.76, p = 0.02) and incorrect empirical antibiotic therapy (OR: 2.01, 95%CI: 1.22–3.33, p = 0.006).

Conclusions: The initial empiric antibiotic treatment is more frequently incorrect in PB than in SB and this is a predictor factor for mortality in PB. The resistance pattern of E. coli, other enterobacterias and S. aureus in every setting should guide the most appropriated empirical treatment for PB.

Session Details

Date: 31/03/2007
Time: 00:00-00:00
Session name: European Society of Clinical Microbiology and Infectious Diseases
Subject:
Location: ICC, Munich, Germany
Presentation type:
Back to top